| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Organic Cation Transport Proteins | 6 | 2013 | 37 | 2.000 |
Why?
|
| Large Neutral Amino Acid-Transporter 1 | 11 | 2019 | 18 | 1.840 |
Why?
|
| beta-Cyclodextrins | 7 | 2015 | 40 | 1.680 |
Why?
|
| Organic Anion Transporters | 6 | 2012 | 28 | 1.650 |
Why?
|
| Antineoplastic Agents | 12 | 2019 | 2071 | 1.230 |
Why?
|
| Benzoxazoles | 6 | 2019 | 23 | 1.070 |
Why?
|
| Epilepsy | 4 | 2020 | 272 | 1.030 |
Why?
|
| Pipecolic Acids | 2 | 2020 | 27 | 0.980 |
Why?
|
| Tyrosine | 6 | 2019 | 244 | 0.980 |
Why?
|
| Dibutyl Phthalate | 6 | 2017 | 8 | 0.890 |
Why?
|
| Drug Stability | 5 | 2017 | 235 | 0.850 |
Why?
|
| ral GTP-Binding Proteins | 2 | 2016 | 5 | 0.810 |
Why?
|
| Dronabinol | 2 | 2019 | 104 | 0.770 |
Why?
|
| Microsomes, Liver | 4 | 2011 | 72 | 0.760 |
Why?
|
| Kidney Tubules, Proximal | 3 | 2013 | 92 | 0.710 |
Why?
|
| Leydig Cells | 5 | 2016 | 16 | 0.710 |
Why?
|
| Cyclodextrins | 2 | 2007 | 18 | 0.690 |
Why?
|
| Freezing | 3 | 2016 | 123 | 0.690 |
Why?
|
| Tamoxifen | 3 | 2007 | 201 | 0.680 |
Why?
|
| Neonatal Screening | 1 | 2019 | 180 | 0.660 |
Why?
|
| Drug Packaging | 2 | 2016 | 56 | 0.650 |
Why?
|
| Anthocyanins | 4 | 2019 | 34 | 0.630 |
Why?
|
| Vitamin E | 4 | 2010 | 123 | 0.630 |
Why?
|
| Pyrazoles | 2 | 2016 | 390 | 0.620 |
Why?
|
| Rats | 21 | 2017 | 6387 | 0.600 |
Why?
|
| Technology, Pharmaceutical | 2 | 2015 | 32 | 0.600 |
Why?
|
| Cold Temperature | 1 | 2016 | 157 | 0.600 |
Why?
|
| Biological Availability | 7 | 2019 | 159 | 0.600 |
Why?
|
| Animals | 61 | 2021 | 35394 | 0.600 |
Why?
|
| Milrinone | 3 | 2021 | 30 | 0.600 |
Why?
|
| Insulin Lispro | 1 | 2015 | 37 | 0.580 |
Why?
|
| Pyridines | 3 | 2019 | 483 | 0.570 |
Why?
|
| Chromatography, Gel | 1 | 2015 | 155 | 0.570 |
Why?
|
| Microsomes | 2 | 2011 | 29 | 0.560 |
Why?
|
| Rats, Sprague-Dawley | 16 | 2017 | 3027 | 0.550 |
Why?
|
| HIV Protease Inhibitors | 3 | 2016 | 76 | 0.540 |
Why?
|
| Chemistry, Pharmaceutical | 8 | 2017 | 161 | 0.520 |
Why?
|
| Cell Line, Tumor | 18 | 2019 | 2936 | 0.510 |
Why?
|
| Benzbromarone | 1 | 2012 | 4 | 0.510 |
Why?
|
| Membrane Transport Modulators | 2 | 2018 | 9 | 0.510 |
Why?
|
| Testosterone | 5 | 2017 | 307 | 0.480 |
Why?
|
| Plant Extracts | 3 | 2020 | 179 | 0.480 |
Why?
|
| Nitriles | 2 | 2016 | 163 | 0.480 |
Why?
|
| Antineoplastic Agents, Phytogenic | 4 | 2019 | 192 | 0.470 |
Why?
|
| Prenatal Exposure Delayed Effects | 5 | 2017 | 467 | 0.460 |
Why?
|
| Pharmaceutical Preparations | 2 | 2013 | 171 | 0.450 |
Why?
|
| Myocytes, Cardiac | 5 | 2020 | 492 | 0.450 |
Why?
|
| Raloxifene Hydrochloride | 2 | 2008 | 17 | 0.450 |
Why?
|
| Fenretinide | 1 | 2010 | 8 | 0.440 |
Why?
|
| Hydroxides | 1 | 2010 | 28 | 0.440 |
Why?
|
| Chromatography, High Pressure Liquid | 6 | 2016 | 595 | 0.440 |
Why?
|
| Mice | 29 | 2021 | 15641 | 0.430 |
Why?
|
| Selective Estrogen Receptor Modulators | 2 | 2007 | 27 | 0.430 |
Why?
|
| Apoptosis | 11 | 2020 | 2675 | 0.430 |
Why?
|
| Triazoles | 2 | 2013 | 144 | 0.420 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2010 | 60 | 0.420 |
Why?
|
| Carnosine | 2 | 2020 | 2 | 0.410 |
Why?
|
| Tretinoin | 1 | 2010 | 120 | 0.400 |
Why?
|
| Momordica charantia | 2 | 2020 | 16 | 0.400 |
Why?
|
| Humans | 68 | 2021 | 113846 | 0.390 |
Why?
|
| Skin Absorption | 1 | 2009 | 12 | 0.390 |
Why?
|
| Ubiquinone | 1 | 2009 | 25 | 0.390 |
Why?
|
| Linoleic Acid | 1 | 2009 | 39 | 0.390 |
Why?
|
| Surface-Active Agents | 2 | 2008 | 98 | 0.380 |
Why?
|
| Epithelial Cells | 3 | 2014 | 1032 | 0.370 |
Why?
|
| Melanocytes | 1 | 2009 | 67 | 0.370 |
Why?
|
| Oligopeptides | 1 | 2010 | 279 | 0.370 |
Why?
|
| Tissue Distribution | 5 | 2021 | 383 | 0.370 |
Why?
|
| Saquinavir | 1 | 2007 | 4 | 0.360 |
Why?
|
| Kidney | 6 | 2021 | 1211 | 0.360 |
Why?
|
| Itraconazole | 1 | 2007 | 11 | 0.360 |
Why?
|
| Maternal Exposure | 4 | 2017 | 134 | 0.350 |
Why?
|
| Chromatography, Liquid | 3 | 2019 | 348 | 0.350 |
Why?
|
| Solubility | 5 | 2009 | 275 | 0.350 |
Why?
|
| Male | 42 | 2021 | 60993 | 0.340 |
Why?
|
| Grape Seed Extract | 3 | 2019 | 46 | 0.340 |
Why?
|
| Fructokinases | 2 | 2018 | 63 | 0.340 |
Why?
|
| Acute Kidney Injury | 3 | 2019 | 613 | 0.340 |
Why?
|
| Injections, Intravenous | 4 | 2007 | 255 | 0.340 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 2184 | 0.330 |
Why?
|
| Cell Proliferation | 12 | 2020 | 2404 | 0.330 |
Why?
|
| Administration, Oral | 5 | 2019 | 798 | 0.330 |
Why?
|
| Biflavonoids | 2 | 2019 | 11 | 0.310 |
Why?
|
| Proanthocyanidins | 2 | 2019 | 12 | 0.310 |
Why?
|
| Pancreatic Neoplasms | 3 | 2020 | 744 | 0.310 |
Why?
|
| Amino Acid Transport System L | 2 | 2017 | 17 | 0.310 |
Why?
|
| Catechin | 2 | 2019 | 27 | 0.300 |
Why?
|
| Vancomycin | 2 | 2018 | 64 | 0.300 |
Why?
|
| Histone Deacetylase Inhibitors | 3 | 2017 | 201 | 0.300 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 2 | 2016 | 43 | 0.300 |
Why?
|
| Neoplastic Stem Cells | 2 | 2019 | 331 | 0.280 |
Why?
|
| Capsules | 3 | 2016 | 41 | 0.270 |
Why?
|
| Atazanavir Sulfate | 2 | 2016 | 49 | 0.260 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2020 | 681 | 0.260 |
Why?
|
| Biomarkers | 3 | 2019 | 3501 | 0.260 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 2020 | 599 | 0.260 |
Why?
|
| Mass Spectrometry | 4 | 2009 | 730 | 0.250 |
Why?
|
| Pyrroles | 2 | 2015 | 199 | 0.250 |
Why?
|
| Estrogen Receptor beta | 2 | 2013 | 36 | 0.250 |
Why?
|
| Molecular Structure | 4 | 2013 | 524 | 0.250 |
Why?
|
| Mice, Nude | 7 | 2020 | 700 | 0.240 |
Why?
|
| Receptors, Androgen | 2 | 2013 | 124 | 0.240 |
Why?
|
| Histone Deacetylases | 2 | 2015 | 211 | 0.240 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2015 | 529 | 0.240 |
Why?
|
| Metabolic Clearance Rate | 4 | 2019 | 140 | 0.240 |
Why?
|
| Liposomes | 2 | 2014 | 164 | 0.230 |
Why?
|
| Lipid Peroxidation | 2 | 2020 | 160 | 0.230 |
Why?
|
| Mepivacaine | 1 | 2001 | 2 | 0.230 |
Why?
|
| Disease Models, Animal | 7 | 2021 | 3910 | 0.230 |
Why?
|
| Biological Transport | 7 | 2016 | 435 | 0.230 |
Why?
|
| Structure-Activity Relationship | 3 | 2012 | 576 | 0.230 |
Why?
|
| STAT3 Transcription Factor | 2 | 2013 | 201 | 0.230 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2013 | 398 | 0.230 |
Why?
|
| Protective Agents | 2 | 2018 | 45 | 0.230 |
Why?
|
| Female | 31 | 2021 | 63035 | 0.230 |
Why?
|
| Ethambutol | 1 | 2021 | 22 | 0.230 |
Why?
|
| Bupivacaine | 1 | 2001 | 35 | 0.220 |
Why?
|
| Lupus Nephritis | 1 | 2021 | 56 | 0.220 |
Why?
|
| Isoenzymes | 2 | 2018 | 367 | 0.220 |
Why?
|
| Mitochondria | 4 | 2017 | 810 | 0.220 |
Why?
|
| Antifungal Agents | 2 | 2015 | 136 | 0.220 |
Why?
|
| Rifampin | 1 | 2021 | 75 | 0.220 |
Why?
|
| Amino Acids, Essential | 2 | 2017 | 11 | 0.220 |
Why?
|
| Peptide Synthases | 1 | 2020 | 7 | 0.220 |
Why?
|
| Drug Storage | 3 | 2017 | 82 | 0.210 |
Why?
|
| Anesthetics, Local | 1 | 2001 | 90 | 0.210 |
Why?
|
| Azithromycin | 1 | 2021 | 82 | 0.210 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2021 | 63 | 0.210 |
Why?
|
| Endothelial Cells | 2 | 2017 | 650 | 0.210 |
Why?
|
| Fusion Regulatory Protein 1, Heavy Chain | 2 | 2017 | 3 | 0.210 |
Why?
|
| beta-Glucans | 2 | 2011 | 21 | 0.210 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2020 | 788 | 0.210 |
Why?
|
| Cannabidiol | 1 | 2020 | 38 | 0.210 |
Why?
|
| Uric Acid | 3 | 2017 | 353 | 0.210 |
Why?
|
| Cell Line | 7 | 2019 | 3016 | 0.200 |
Why?
|
| Dichloroacetic Acid | 1 | 1999 | 2 | 0.200 |
Why?
|
| Hirudins | 1 | 2020 | 49 | 0.200 |
Why?
|
| Macaca fascicularis | 2 | 2011 | 52 | 0.200 |
Why?
|
| Antithrombins | 1 | 2020 | 57 | 0.200 |
Why?
|
| Temperature | 4 | 2017 | 667 | 0.200 |
Why?
|
| Deoxycytidine | 1 | 2020 | 146 | 0.200 |
Why?
|
| Kinetics | 3 | 2013 | 1800 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2017 | 158 | 0.200 |
Why?
|
| Dogs | 3 | 2011 | 472 | 0.200 |
Why?
|
| Phosphodiesterase 3 Inhibitors | 1 | 2019 | 14 | 0.200 |
Why?
|
| Biotransformation | 3 | 2013 | 89 | 0.200 |
Why?
|
| Area Under Curve | 2 | 2012 | 328 | 0.200 |
Why?
|
| Deuterium | 1 | 1999 | 88 | 0.190 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2020 | 157 | 0.190 |
Why?
|
| Glutathione Transferase | 1 | 1999 | 119 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2017 | 190 | 0.190 |
Why?
|
| Thrombin | 1 | 2020 | 125 | 0.190 |
Why?
|
| Transfection | 5 | 2016 | 997 | 0.190 |
Why?
|
| Taurine | 1 | 2019 | 42 | 0.190 |
Why?
|
| Cell Survival | 7 | 2019 | 1188 | 0.190 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2019 | 64 | 0.190 |
Why?
|
| Substrate Specificity | 4 | 2014 | 405 | 0.190 |
Why?
|
| Dipeptides | 1 | 2018 | 52 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2019 | 2229 | 0.190 |
Why?
|
| Acetates | 1 | 1999 | 106 | 0.190 |
Why?
|
| Fructose Intolerance | 1 | 2018 | 5 | 0.190 |
Why?
|
| Polyethylene Glycols | 5 | 2011 | 588 | 0.190 |
Why?
|
| HIV Integrase | 1 | 2019 | 60 | 0.190 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2019 | 49 | 0.190 |
Why?
|
| Homocystinuria | 1 | 2019 | 58 | 0.180 |
Why?
|
| Phospholipids | 2 | 2013 | 205 | 0.180 |
Why?
|
| Anticonvulsants | 1 | 2020 | 202 | 0.180 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2018 | 11 | 0.180 |
Why?
|
| Oxidative Stress | 4 | 2019 | 1244 | 0.180 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2017 | 91 | 0.180 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2020 | 189 | 0.180 |
Why?
|
| Dual Specificity Phosphatase 6 | 1 | 2017 | 7 | 0.180 |
Why?
|
| Protein Multimerization | 1 | 2019 | 169 | 0.180 |
Why?
|
| Rhodamine 123 | 2 | 2008 | 7 | 0.180 |
Why?
|
| Medulloblastoma | 2 | 2019 | 163 | 0.180 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2019 | 140 | 0.180 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2018 | 44 | 0.180 |
Why?
|
| Butylhydroxybutylnitrosamine | 1 | 2017 | 8 | 0.170 |
Why?
|
| Liver | 4 | 2011 | 1867 | 0.170 |
Why?
|
| Rats, Inbred Strains | 2 | 2008 | 536 | 0.170 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2015 | 152 | 0.170 |
Why?
|
| Suspensions | 1 | 2017 | 33 | 0.170 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 17 | 0.170 |
Why?
|
| Luteolin | 1 | 2017 | 5 | 0.170 |
Why?
|
| Prostatic Neoplasms | 4 | 2019 | 1015 | 0.170 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2018 | 300 | 0.170 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 4 | 2019 | 97 | 0.170 |
Why?
|
| Sexual Maturation | 1 | 2017 | 55 | 0.170 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 249 | 0.170 |
Why?
|
| Medical Marijuana | 1 | 2019 | 119 | 0.170 |
Why?
|
| Aging | 2 | 2019 | 1713 | 0.160 |
Why?
|
| Hydroxychloroquine | 1 | 2017 | 58 | 0.160 |
Why?
|
| Gene Expression | 2 | 2016 | 1588 | 0.160 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 58 | 0.160 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2016 | 44 | 0.160 |
Why?
|
| Caco-2 Cells | 4 | 2010 | 77 | 0.160 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2016 | 19 | 0.160 |
Why?
|
| Microvessels | 1 | 2017 | 80 | 0.160 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 59 | 0.160 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2017 | 152 | 0.160 |
Why?
|
| Cell Movement | 3 | 2019 | 936 | 0.160 |
Why?
|
| Alzheimer Disease | 1 | 2021 | 420 | 0.160 |
Why?
|
| Testis | 4 | 2017 | 130 | 0.160 |
Why?
|
| Creatinine | 1 | 2018 | 461 | 0.160 |
Why?
|
| Psychotropic Drugs | 1 | 2016 | 57 | 0.160 |
Why?
|
| Leucine | 5 | 2017 | 117 | 0.150 |
Why?
|
| Recombinant Proteins | 3 | 2020 | 1458 | 0.150 |
Why?
|
| Colonic Neoplasms | 1 | 2018 | 226 | 0.150 |
Why?
|
| Infant, Newborn | 4 | 2019 | 5080 | 0.150 |
Why?
|
| Adenosine Triphosphate | 3 | 2020 | 465 | 0.150 |
Why?
|
| African Americans | 2 | 2013 | 1101 | 0.150 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 353 | 0.150 |
Why?
|
| Critical Illness | 2 | 2018 | 584 | 0.150 |
Why?
|
| Drug Discovery | 1 | 2016 | 131 | 0.150 |
Why?
|
| Immunohistochemistry | 5 | 2017 | 1831 | 0.150 |
Why?
|
| Oligomycins | 1 | 2014 | 9 | 0.150 |
Why?
|
| Therapeutics | 1 | 2015 | 13 | 0.150 |
Why?
|
| Peptide Fragments | 1 | 2020 | 740 | 0.150 |
Why?
|
| Cell Shape | 2 | 2015 | 58 | 0.150 |
Why?
|
| Luteinizing Hormone | 2 | 2013 | 188 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 1210 | 0.150 |
Why?
|
| Edetic Acid | 1 | 2015 | 50 | 0.150 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2014 | 19 | 0.150 |
Why?
|
| Rats, Wistar | 3 | 2017 | 416 | 0.150 |
Why?
|
| Pentacyclic Triterpenes | 1 | 2014 | 13 | 0.140 |
Why?
|
| Pyrimidines | 2 | 2016 | 402 | 0.140 |
Why?
|
| Voriconazole | 1 | 2015 | 24 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 4 | 2020 | 1041 | 0.140 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 155 | 0.140 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2016 | 168 | 0.140 |
Why?
|
| Hydroxamic Acids | 1 | 2015 | 87 | 0.140 |
Why?
|
| Renal Replacement Therapy | 1 | 2015 | 59 | 0.140 |
Why?
|
| Carbazoles | 1 | 2015 | 90 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2015 | 86 | 0.140 |
Why?
|
| Scattering, Radiation | 1 | 2015 | 121 | 0.140 |
Why?
|
| Chelating Agents | 1 | 2015 | 88 | 0.140 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2016 | 450 | 0.140 |
Why?
|
| Cell Cycle | 2 | 2015 | 603 | 0.140 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2017 | 192 | 0.140 |
Why?
|
| Integrins | 1 | 2015 | 78 | 0.140 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2019 | 482 | 0.140 |
Why?
|
| Pharmacogenetics | 1 | 2016 | 170 | 0.140 |
Why?
|
| Proteolysis | 1 | 2015 | 146 | 0.140 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2014 | 60 | 0.140 |
Why?
|
| Cisplatin | 1 | 2016 | 284 | 0.140 |
Why?
|
| Sulfurtransferases | 1 | 2013 | 9 | 0.140 |
Why?
|
| Glutaredoxins | 1 | 2013 | 11 | 0.140 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 447 | 0.140 |
Why?
|
| Drug Dosage Calculations | 1 | 2014 | 26 | 0.140 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2014 | 111 | 0.140 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2014 | 96 | 0.140 |
Why?
|
| Tyrphostins | 1 | 2013 | 18 | 0.140 |
Why?
|
| Small Molecule Libraries | 1 | 2014 | 83 | 0.130 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2013 | 188 | 0.130 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2014 | 197 | 0.130 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 711 | 0.130 |
Why?
|
| Tetraethylammonium | 1 | 2013 | 17 | 0.130 |
Why?
|
| Organic Cation Transporter 2 | 1 | 2013 | 13 | 0.130 |
Why?
|
| Polyvinyl Chloride | 1 | 2013 | 8 | 0.130 |
Why?
|
| Phosphoproteins | 1 | 2016 | 335 | 0.130 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2013 | 12 | 0.130 |
Why?
|
| Hyperoxia | 1 | 2014 | 95 | 0.130 |
Why?
|
| Status Epilepticus | 1 | 2013 | 33 | 0.130 |
Why?
|
| Momordica | 1 | 2013 | 3 | 0.130 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2013 | 30 | 0.130 |
Why?
|
| Endoplasmic Reticulum, Smooth | 1 | 2013 | 6 | 0.130 |
Why?
|
| Ferrous Compounds | 1 | 2013 | 26 | 0.130 |
Why?
|
| Hyperglycinemia, Nonketotic | 1 | 2013 | 43 | 0.130 |
Why?
|
| Mouth Neoplasms | 1 | 2014 | 87 | 0.130 |
Why?
|
| Half-Life | 3 | 2019 | 187 | 0.130 |
Why?
|
| Endoplasmic Reticulum | 1 | 2015 | 250 | 0.130 |
Why?
|
| Muscle Proteins | 1 | 2015 | 214 | 0.130 |
Why?
|
| Prospective Studies | 6 | 2021 | 6250 | 0.130 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2013 | 54 | 0.130 |
Why?
|
| Dexmedetomidine | 1 | 2013 | 54 | 0.130 |
Why?
|
| Antiviral Agents | 1 | 2019 | 639 | 0.130 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2014 | 97 | 0.130 |
Why?
|
| Heptanoic Acids | 1 | 2013 | 68 | 0.130 |
Why?
|
| NF-kappa B | 2 | 2014 | 719 | 0.120 |
Why?
|
| Trace Elements | 1 | 2013 | 46 | 0.120 |
Why?
|
| Protein Kinase C | 1 | 2015 | 354 | 0.120 |
Why?
|
| Xenopus laevis | 6 | 2010 | 161 | 0.120 |
Why?
|
| Silymarin | 1 | 2014 | 212 | 0.120 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 291 | 0.120 |
Why?
|
| Estrogen Receptor alpha | 1 | 2013 | 113 | 0.120 |
Why?
|
| Reactive Oxygen Species | 2 | 2017 | 560 | 0.120 |
Why?
|
| Lung | 2 | 2016 | 3637 | 0.120 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2013 | 44 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 1121 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 3 | 2021 | 1331 | 0.120 |
Why?
|
| Xenopus | 2 | 2011 | 127 | 0.120 |
Why?
|
| Nitric Oxide | 2 | 2016 | 883 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2014 | 226 | 0.120 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 175 | 0.120 |
Why?
|
| Pyrazines | 1 | 2013 | 86 | 0.120 |
Why?
|
| Sodium Chloride | 1 | 2013 | 173 | 0.120 |
Why?
|
| Candida glabrata | 1 | 2011 | 1 | 0.120 |
Why?
|
| Chalcones | 1 | 2011 | 10 | 0.120 |
Why?
|
| Signal Transduction | 6 | 2016 | 4923 | 0.120 |
Why?
|
| Cystic Fibrosis | 1 | 2021 | 893 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 5249 | 0.120 |
Why?
|
| Methylnitronitrosoguanidine | 1 | 2011 | 2 | 0.120 |
Why?
|
| Electricity | 1 | 2011 | 24 | 0.120 |
Why?
|
| Metals | 1 | 2013 | 124 | 0.120 |
Why?
|
| Anions | 1 | 2011 | 37 | 0.120 |
Why?
|
| Coronary Artery Bypass | 1 | 2014 | 271 | 0.120 |
Why?
|
| Cardiomegaly | 1 | 2013 | 172 | 0.120 |
Why?
|
| Hepatocytes | 1 | 2013 | 203 | 0.120 |
Why?
|
| Glucuronides | 1 | 2011 | 21 | 0.120 |
Why?
|
| Carnitine | 2 | 2010 | 67 | 0.120 |
Why?
|
| Thiazolidinediones | 1 | 2013 | 161 | 0.120 |
Why?
|
| Cell Wall | 1 | 2011 | 46 | 0.120 |
Why?
|
| RNA, Messenger | 4 | 2017 | 2857 | 0.120 |
Why?
|
| Oxidation-Reduction | 2 | 2016 | 1050 | 0.120 |
Why?
|
| Light | 1 | 2015 | 385 | 0.120 |
Why?
|
| Zinc | 1 | 2015 | 280 | 0.120 |
Why?
|
| In Vitro Techniques | 2 | 2017 | 1268 | 0.120 |
Why?
|
| Erythrocytes | 1 | 2017 | 609 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 574 | 0.110 |
Why?
|
| Fibroblasts | 1 | 2017 | 906 | 0.110 |
Why?
|
| Buffers | 2 | 2013 | 81 | 0.110 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2016 | 296 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2016 | 858 | 0.110 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2014 | 188 | 0.110 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 407 | 0.110 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2010 | 5 | 0.110 |
Why?
|
| Surgical Wound Infection | 1 | 2014 | 224 | 0.110 |
Why?
|
| Stomach Neoplasms | 1 | 2011 | 74 | 0.110 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type I | 1 | 2010 | 3 | 0.110 |
Why?
|
| Bumetanide | 1 | 2010 | 4 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 380 | 0.110 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 804 | 0.110 |
Why?
|
| Cell Polarity | 1 | 2011 | 136 | 0.110 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2010 | 22 | 0.110 |
Why?
|
| Acetylation | 1 | 2011 | 226 | 0.110 |
Why?
|
| Furosemide | 1 | 2010 | 30 | 0.110 |
Why?
|
| DNA Fragmentation | 1 | 2010 | 62 | 0.110 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2016 | 481 | 0.110 |
Why?
|
| Hospitalization | 1 | 2020 | 1678 | 0.110 |
Why?
|
| Antioxidants | 1 | 2014 | 570 | 0.110 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 364 | 0.110 |
Why?
|
| Ritonavir | 1 | 2010 | 63 | 0.110 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 649 | 0.110 |
Why?
|
| Oocytes | 6 | 2010 | 228 | 0.110 |
Why?
|
| Electron Transport Complex IV | 1 | 2010 | 72 | 0.110 |
Why?
|
| Protein Kinases | 1 | 2013 | 340 | 0.110 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 177 | 0.110 |
Why?
|
| Permeability | 1 | 2010 | 161 | 0.110 |
Why?
|
| Drug Carriers | 2 | 2008 | 134 | 0.110 |
Why?
|
| Immunoblotting | 3 | 2017 | 375 | 0.110 |
Why?
|
| Cell Death | 3 | 2017 | 348 | 0.100 |
Why?
|
| Diuretics | 1 | 2010 | 84 | 0.100 |
Why?
|
| Intestine, Small | 1 | 2011 | 149 | 0.100 |
Why?
|
| Gene Transfer Techniques | 1 | 2011 | 155 | 0.100 |
Why?
|
| Quinidine | 1 | 2009 | 7 | 0.100 |
Why?
|
| Drug Design | 1 | 2011 | 177 | 0.100 |
Why?
|
| Cardiac Output, Low | 2 | 2021 | 78 | 0.100 |
Why?
|
| Neurons | 1 | 2019 | 1493 | 0.100 |
Why?
|
| Time Factors | 3 | 2016 | 7060 | 0.100 |
Why?
|
| Verapamil | 1 | 2009 | 36 | 0.100 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 441 | 0.100 |
Why?
|
| Acrolein | 2 | 2020 | 30 | 0.100 |
Why?
|
| Digoxin | 1 | 2009 | 33 | 0.100 |
Why?
|
| Vinblastine | 1 | 2009 | 82 | 0.100 |
Why?
|
| Ear, External | 1 | 2009 | 30 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2014 | 1123 | 0.100 |
Why?
|
| Anti-HIV Agents | 1 | 2016 | 681 | 0.100 |
Why?
|
| Aortic Valve | 1 | 2014 | 449 | 0.100 |
Why?
|
| Cholesterol | 1 | 2011 | 386 | 0.100 |
Why?
|
| Animals, Newborn | 3 | 2017 | 867 | 0.100 |
Why?
|
| Mice, Knockout | 4 | 2018 | 2893 | 0.100 |
Why?
|
| Glyburide | 1 | 2009 | 43 | 0.100 |
Why?
|
| Pregnancy | 6 | 2017 | 5290 | 0.090 |
Why?
|
| Cardiotonic Agents | 2 | 2021 | 139 | 0.090 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 388 | 0.090 |
Why?
|
| Imatinib Mesylate | 2 | 2021 | 68 | 0.090 |
Why?
|
| Enzyme Activation | 3 | 2017 | 960 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2017 | 4429 | 0.090 |
Why?
|
| 2-Hydroxypropyl-beta-cyclodextrin | 1 | 2007 | 8 | 0.090 |
Why?
|
| Food-Drug Interactions | 1 | 2007 | 11 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 346 | 0.090 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 737 | 0.090 |
Why?
|
| Doxorubicin | 1 | 2009 | 312 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2013 | 991 | 0.090 |
Why?
|
| Organic Anion Transport Protein 1 | 2 | 2010 | 8 | 0.090 |
Why?
|
| Models, Biological | 2 | 2019 | 1845 | 0.090 |
Why?
|
| Mice, Transgenic | 3 | 2021 | 2161 | 0.090 |
Why?
|
| Proteins | 1 | 2013 | 998 | 0.080 |
Why?
|
| Mutation | 2 | 2019 | 3447 | 0.080 |
Why?
|
| Body Weight | 3 | 2019 | 1020 | 0.080 |
Why?
|
| Brain | 3 | 2021 | 2686 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 960 | 0.080 |
Why?
|
| S-Nitrosothiols | 2 | 2017 | 6 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 461 | 0.080 |
Why?
|
| Adenosine Triphosphatases | 1 | 2007 | 185 | 0.080 |
Why?
|
| Prostate | 2 | 2019 | 153 | 0.080 |
Why?
|
| Cross-Over Studies | 2 | 2021 | 484 | 0.080 |
Why?
|
| Fructose | 2 | 2018 | 190 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2014 | 1643 | 0.080 |
Why?
|
| Child | 6 | 2021 | 17711 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2008 | 400 | 0.080 |
Why?
|
| Particle Size | 2 | 2021 | 409 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 1423 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 3 | 2014 | 1326 | 0.070 |
Why?
|
| Sex Factors | 2 | 2011 | 1997 | 0.070 |
Why?
|
| Methylation | 2 | 2018 | 219 | 0.070 |
Why?
|
| Drug Compounding | 2 | 2017 | 97 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2013 | 1044 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 2052 | 0.070 |
Why?
|
| Middle Aged | 8 | 2020 | 28753 | 0.070 |
Why?
|
| Cysteine | 2 | 2017 | 207 | 0.070 |
Why?
|
| Cell Adhesion | 2 | 2017 | 474 | 0.070 |
Why?
|
| Carbohydrates | 2 | 2014 | 65 | 0.070 |
Why?
|
| Mice, Inbred NOD | 2 | 2016 | 564 | 0.070 |
Why?
|
| Drug Administration Schedule | 2 | 2018 | 825 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2019 | 666 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 1930 | 0.070 |
Why?
|
| Models, Molecular | 3 | 2019 | 1604 | 0.070 |
Why?
|
| Freeze Drying | 2 | 2014 | 162 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2020 | 975 | 0.060 |
Why?
|
| Protein Binding | 3 | 2017 | 2115 | 0.060 |
Why?
|
| Phosphatidylcholines | 2 | 2014 | 133 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 634 | 0.060 |
Why?
|
| Membrane Proteins | 2 | 2008 | 1098 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2016 | 608 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 1909 | 0.060 |
Why?
|
| United States | 3 | 2019 | 12329 | 0.060 |
Why?
|
| Intestinal Mucosa | 1 | 2007 | 526 | 0.060 |
Why?
|
| Adult | 7 | 2020 | 31979 | 0.060 |
Why?
|
| Mitochondrial Proteins | 2 | 2014 | 228 | 0.060 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2014 | 366 | 0.060 |
Why?
|
| RNA Interference | 2 | 2014 | 515 | 0.060 |
Why?
|
| Chemical Precipitation | 1 | 2001 | 43 | 0.060 |
Why?
|
| Antibiotics, Antitubercular | 1 | 2021 | 39 | 0.060 |
Why?
|
| HIV Infections | 1 | 2016 | 2487 | 0.060 |
Why?
|
| Liver X Receptors | 1 | 2021 | 32 | 0.060 |
Why?
|
| Sodium Bicarbonate | 1 | 2001 | 46 | 0.060 |
Why?
|
| Membrane Transport Proteins | 1 | 2002 | 162 | 0.060 |
Why?
|
| Adenosine Monophosphate | 1 | 2021 | 51 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2001 | 365 | 0.050 |
Why?
|
| Acetylcysteine | 1 | 2001 | 150 | 0.050 |
Why?
|
| Mycobacterium avium Complex | 1 | 2021 | 93 | 0.050 |
Why?
|
| beta-Alanine | 1 | 2020 | 24 | 0.050 |
Why?
|
| Thrombin Time | 1 | 2020 | 12 | 0.050 |
Why?
|
| Polymorphism, Genetic | 2 | 2016 | 775 | 0.050 |
Why?
|
| Genotype | 2 | 2019 | 2074 | 0.050 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2020 | 84 | 0.050 |
Why?
|
| Glyoxylates | 1 | 1999 | 7 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2014 | 1316 | 0.050 |
Why?
|
| Drug Interactions | 2 | 2013 | 423 | 0.050 |
Why?
|
| Lipids | 2 | 2014 | 629 | 0.050 |
Why?
|
| Antitubercular Agents | 1 | 2021 | 166 | 0.050 |
Why?
|
| Infant | 3 | 2019 | 8090 | 0.050 |
Why?
|
| 2-Aminoadipic Acid | 1 | 2019 | 9 | 0.050 |
Why?
|
| Jagged-1 Protein | 1 | 2019 | 28 | 0.050 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2019 | 14 | 0.050 |
Why?
|
| Aldehydes | 1 | 2020 | 181 | 0.050 |
Why?
|
| Stereoisomerism | 1 | 2019 | 134 | 0.050 |
Why?
|
| Allosteric Regulation | 1 | 2019 | 88 | 0.050 |
Why?
|
| Cell Hypoxia | 1 | 2020 | 238 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 454 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2020 | 412 | 0.050 |
Why?
|
| Monte Carlo Method | 1 | 2019 | 160 | 0.050 |
Why?
|
| Receptor, Notch1 | 1 | 2019 | 66 | 0.050 |
Why?
|
| Spheroids, Cellular | 1 | 2019 | 57 | 0.050 |
Why?
|
| Arginine | 1 | 2020 | 252 | 0.050 |
Why?
|
| Epithelial Cell Adhesion Molecule | 1 | 2018 | 11 | 0.050 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 2018 | 7 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2021 | 170 | 0.050 |
Why?
|
| CD24 Antigen | 1 | 2018 | 20 | 0.050 |
Why?
|
| Biological Transport, Active | 2 | 2009 | 77 | 0.050 |
Why?
|
| Fruit and Vegetable Juices | 1 | 2018 | 14 | 0.050 |
Why?
|
| Homocysteine | 1 | 2019 | 143 | 0.050 |
Why?
|
| Amino Acids | 1 | 2002 | 420 | 0.050 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2018 | 12 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2018 | 27 | 0.050 |
Why?
|
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2018 | 38 | 0.050 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 167 | 0.050 |
Why?
|
| Absorption, Physiological | 1 | 2018 | 6 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2019 | 310 | 0.050 |
Why?
|
| Hyaluronan Receptors | 1 | 2018 | 94 | 0.040 |
Why?
|
| Protein Domains | 1 | 2019 | 212 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2019 | 251 | 0.040 |
Why?
|
| Coumarins | 1 | 2017 | 19 | 0.040 |
Why?
|
| Seminiferous Tubules | 1 | 2017 | 9 | 0.040 |
Why?
|
| Glutamine | 1 | 2018 | 80 | 0.040 |
Why?
|
| Sertoli Cells | 1 | 2017 | 19 | 0.040 |
Why?
|
| Amino Acids, Cyclic | 1 | 2017 | 3 | 0.040 |
Why?
|
| Reticulocytes | 1 | 2017 | 18 | 0.040 |
Why?
|
| Brachial Artery | 1 | 2019 | 194 | 0.040 |
Why?
|
| Erythrocyte Deformability | 1 | 2017 | 11 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 118 | 0.040 |
Why?
|
| Clone Cells | 1 | 2018 | 261 | 0.040 |
Why?
|
| Organic Anion Transporters, Sodium-Independent | 2 | 2010 | 6 | 0.040 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 119 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2002 | 824 | 0.040 |
Why?
|
| Polyethylene Terephthalates | 1 | 2017 | 15 | 0.040 |
Why?
|
| Plastics | 1 | 2017 | 34 | 0.040 |
Why?
|
| Amino Acid Transport Systems | 1 | 2017 | 42 | 0.040 |
Why?
|
| Histone Deacetylase 1 | 1 | 2017 | 18 | 0.040 |
Why?
|
| Astrocytes | 1 | 2019 | 165 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2018 | 268 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2019 | 639 | 0.040 |
Why?
|
| Intracellular Space | 1 | 2017 | 81 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 82 | 0.040 |
Why?
|
| Thoracic Surgery | 1 | 2018 | 120 | 0.040 |
Why?
|
| Rabies | 1 | 1976 | 1 | 0.040 |
Why?
|
| Cerebellum | 1 | 2019 | 246 | 0.040 |
Why?
|
| Fusion Regulatory Protein-1 | 1 | 2016 | 2 | 0.040 |
Why?
|
| Antelopes | 1 | 1976 | 3 | 0.040 |
Why?
|
| Mephitidae | 1 | 1976 | 3 | 0.040 |
Why?
|
| Benzothiazoles | 1 | 2016 | 42 | 0.040 |
Why?
|
| Hydrazines | 1 | 2016 | 37 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 2013 | 314 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2017 | 464 | 0.040 |
Why?
|
| Syringes | 1 | 2017 | 68 | 0.040 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2016 | 11 | 0.040 |
Why?
|
| Polymers | 1 | 2021 | 479 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 131 | 0.040 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2015 | 4 | 0.040 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 1 | 2015 | 10 | 0.040 |
Why?
|
| Aldehyde Reductase | 1 | 2017 | 106 | 0.040 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2015 | 5 | 0.040 |
Why?
|
| Age Factors | 2 | 2015 | 3330 | 0.040 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2017 | 220 | 0.040 |
Why?
|
| Peru | 1 | 2016 | 64 | 0.040 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 87 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2020 | 450 | 0.040 |
Why?
|
| Organ Size | 1 | 2017 | 499 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2018 | 390 | 0.040 |
Why?
|
| Papio | 1 | 2016 | 99 | 0.040 |
Why?
|
| Young Adult | 3 | 2019 | 10971 | 0.040 |
Why?
|
| South Africa | 1 | 2016 | 151 | 0.040 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2016 | 66 | 0.040 |
Why?
|
| Pyrimidinones | 1 | 2016 | 89 | 0.040 |
Why?
|
| Dihydrolipoyllysine-Residue Acetyltransferase | 1 | 2014 | 7 | 0.040 |
Why?
|
| Ketone Oxidoreductases | 1 | 2014 | 8 | 0.040 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2014 | 38 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2017 | 352 | 0.040 |
Why?
|
| Glycerylphosphorylcholine | 1 | 2014 | 6 | 0.040 |
Why?
|
| Cannabis | 1 | 2020 | 292 | 0.040 |
Why?
|
| Soluble Guanylyl Cyclase | 1 | 2014 | 16 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2014 | 61 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2016 | 360 | 0.040 |
Why?
|
| Transition Temperature | 1 | 2014 | 35 | 0.040 |
Why?
|
| Guanylate Cyclase | 1 | 2014 | 40 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 2014 | 86 | 0.040 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2014 | 70 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 442 | 0.040 |
Why?
|
| Trehalose | 1 | 2014 | 58 | 0.040 |
Why?
|
| GTPase-Activating Proteins | 1 | 2014 | 73 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 230 | 0.030 |
Why?
|
| Dacarbazine | 1 | 2014 | 109 | 0.030 |
Why?
|
| Allografts | 1 | 2014 | 106 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 2014 | 45 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 330 | 0.030 |
Why?
|
| Superoxides | 1 | 2014 | 252 | 0.030 |
Why?
|
| Pilocarpine | 1 | 2013 | 10 | 0.030 |
Why?
|
| Ischemia | 1 | 2017 | 314 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 441 | 0.030 |
Why?
|
| Dentate Gyrus | 1 | 2013 | 37 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2014 | 129 | 0.030 |
Why?
|
| Cytochrome P-450 CYP2C8 | 1 | 2013 | 18 | 0.030 |
Why?
|
| Bile | 1 | 2013 | 30 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2020 | 902 | 0.030 |
Why?
|
| Sulfites | 1 | 2013 | 8 | 0.030 |
Why?
|
| Atrophy | 1 | 2013 | 140 | 0.030 |
Why?
|
| ras Proteins | 1 | 2014 | 155 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2014 | 281 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 219 | 0.030 |
Why?
|
| Ligands | 2 | 2008 | 532 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 1004 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 1421 | 0.030 |
Why?
|
| Sitagliptin Phosphate | 1 | 2013 | 29 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2020 | 9002 | 0.030 |
Why?
|
| Drug Contamination | 1 | 2013 | 68 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2015 | 236 | 0.030 |
Why?
|
| Injections | 1 | 2013 | 164 | 0.030 |
Why?
|
| Colorado | 2 | 2014 | 4581 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2012 | 99 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 2013 | 230 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 210 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 1414 | 0.030 |
Why?
|
| Sucrose | 1 | 2013 | 143 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 1976 | 526 | 0.030 |
Why?
|
| Caspases | 1 | 2014 | 293 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2014 | 191 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2013 | 219 | 0.030 |
Why?
|
| Benzamides | 1 | 2013 | 186 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2016 | 449 | 0.030 |
Why?
|
| Cytosol | 1 | 2013 | 250 | 0.030 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2011 | 9 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2012 | 162 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2013 | 256 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2014 | 253 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2011 | 58 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2010 | 2229 | 0.030 |
Why?
|
| Hippocampus | 2 | 2013 | 795 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2016 | 566 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2013 | 572 | 0.030 |
Why?
|
| Dimerization | 1 | 2011 | 209 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2010 | 3118 | 0.030 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2010 | 8 | 0.030 |
Why?
|
| Oxygen | 1 | 2016 | 892 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2013 | 499 | 0.030 |
Why?
|
| Ion Transport | 1 | 2010 | 64 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2014 | 1184 | 0.030 |
Why?
|
| Urate Oxidase | 1 | 2010 | 31 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 415 | 0.030 |
Why?
|
| Neoplasms | 2 | 2014 | 2037 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 909 | 0.030 |
Why?
|
| Seizures | 1 | 2013 | 339 | 0.030 |
Why?
|
| Fusion Regulatory Protein 1, Light Chains | 1 | 2009 | 7 | 0.030 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2009 | 7 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2009 | 41 | 0.030 |
Why?
|
| Gout | 1 | 2010 | 54 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2014 | 948 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2013 | 626 | 0.030 |
Why?
|
| Microinjections | 1 | 2009 | 121 | 0.020 |
Why?
|
| Surface Properties | 1 | 2011 | 431 | 0.020 |
Why?
|
| Differential Thermal Analysis | 1 | 2009 | 1 | 0.020 |
Why?
|
| Gastric Juice | 1 | 2009 | 7 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2010 | 369 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 2009 | 87 | 0.020 |
Why?
|
| Gelatin | 1 | 2009 | 35 | 0.020 |
Why?
|
| Hyperuricemia | 1 | 2010 | 136 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 945 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2013 | 1742 | 0.020 |
Why?
|
| Mitosporic Fungi | 1 | 2008 | 10 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2010 | 324 | 0.020 |
Why?
|
| Carbohydrate Conformation | 1 | 2008 | 32 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 20109 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2008 | 75 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2009 | 125 | 0.020 |
Why?
|
| Yeasts | 1 | 2008 | 65 | 0.020 |
Why?
|
| Inflammation | 1 | 2019 | 2451 | 0.020 |
Why?
|
| Membrane Fluidity | 1 | 2007 | 13 | 0.020 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2007 | 97 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2010 | 974 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 416 | 0.020 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2006 | 17 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 1397 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 2828 | 0.020 |
Why?
|
| Rabbits | 1 | 2006 | 818 | 0.020 |
Why?
|
| Solute Carrier Proteins | 1 | 2002 | 1 | 0.020 |
Why?
|
| Solute Carrier Family 22 Member 5 | 1 | 2002 | 5 | 0.020 |
Why?
|
| Epididymis | 1 | 2002 | 11 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 2629 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2013 | 5011 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2002 | 225 | 0.020 |
Why?
|
| Symporters | 1 | 2002 | 61 | 0.020 |
Why?
|
| p-Aminohippuric Acid | 1 | 2001 | 9 | 0.010 |
Why?
|
| Tritium | 1 | 2001 | 81 | 0.010 |
Why?
|
| Gene Library | 1 | 2002 | 117 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 1517 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 299 | 0.010 |
Why?
|
| Spermatozoa | 1 | 2002 | 104 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 410 | 0.010 |
Why?
|
| Introns | 1 | 2002 | 243 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2008 | 763 | 0.010 |
Why?
|
| Exons | 1 | 2002 | 317 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 599 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 2424 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 18736 | 0.010 |
Why?
|
| Models, Chemical | 1 | 2002 | 308 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2016 | 11340 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 9717 | 0.010 |
Why?
|
| Phylogeny | 1 | 2002 | 789 | 0.010 |
Why?
|
| Software | 1 | 2002 | 618 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 1976 | 8 | 0.010 |
Why?
|
| South Dakota | 1 | 1976 | 9 | 0.010 |
Why?
|
| Disease Reservoirs | 1 | 1976 | 21 | 0.010 |
Why?
|